Brief: Syntara Seeks Trading Halt
27/04/2026 02:21
April 27 (Reuters) - Syntara Ltd SNT.AX: TRADING HALT PENDING ANNOUNCEMENT ON FDA CORRESPONDENCE FOR AMSULOSTAT PHASE 2B TRIAL PROTOCOL Further company coverage: SNT.AX ((Reuters.Briefs@thomsonreuters.com;))